RNE Honors Rare Disease Day Speaker Series 2019
RNE Honors Rare Disease Day Speaker Series 2019 - sponsors
Dr. Mark Korson is an RNE Board Member. He is currently Director of Physician Support and Director of Education at VMP Genetics, and co-directs the North American Metabolic Academy . He is a clinical biochemical geneticist, focusing on the development of a telehealth approach to metabolic care (helping physicians with diagnosis and management), and promotes education as a way of addressing the current workforce issue in metabolic medicine. Click here to review his profile.
Last year's series was a great success as we visited 6 academic facilities! For 2019, we are bringing educational opportunities to several several new venues across the New England area:
- Brandeis University Genetic Counseling Program*
- Yale-New Haven Medical Center
- University of New England
- Dartmouth-Hitchcock Medical Center*
- University of Vermont Medical Center
- Boston University School of Medicine Genetic Counseling Program*
- Bay Path University Genetics Counseling Program*
RNE is fortunate to have world-renowned geneticists within our organization who often provide their expertise through our events. Dr. Korson spearheads the Rare Disease Day Speaker Series which is based off his own experiences bringing in patients "Whereas physicians usually teach facts and discuss patient cases, patients (or family members) tell stories. People love stories. Story-telling is a far more effective teaching method than didactic teaching, and no one can discuss a disorder or describe in a more compelling way what it’s like to have a disease than someone who actually lives with that condition.".
During the weeks around Rare Disease Day, RNE arranges for patients and/or family members to speak to medical audiences at major teaching hospitals, medical schools and genetic counseling programs around New England. The presentation topics includes any combination of the following possibilities: the diagnostic journey, living with the disease, coping strategies, challenges in the healthcare and/or educational systems, and others.
At each event, the patient presentation is preceded by a brief clinical overview of the disease by a geneticist to ensure that the audience has a medical foundation about the condition.
These sessions provide the medical community the chance to see patients with disorders they might not otherwise see. This opportunity also makes it more likely that they will recognize such patients in the future